Project overview
Idiopathic pulmonary fibrosis (IPF) is a life-threatening condition of the lungs where tissue becomes thickened, stiff, and scarred, limiting the amount of oxygen getting into the blood. The aim of this project is to provide effective targeted therapies for sufferers to reduce symptoms of this devastating disease and improve their quality of life as well as to identify biomarkers for IPF patients.
Staff
Lead researchers
Collaborating research institutes, centres and groups
Research outputs
Charlotte Hill & Yihua Wang,
2022, Genes and Diseases, 9(6), 1594-1607
Type: review
Hualong Zhao, Siyuan Wang, Yilu Zhou, Ayse Ertay, Philip Williamson, Robert Ewing, Xinhui Tang, Jialian Wang & Yihua Wang,
2022, Frontiers in Plant Science, 13
Type: article
Xiaofan Liu, Fang Ni, Tao Guo, Fangfang Jiang, Yan Jiang, Cheng Song, Mingli Yuan, Zhaowu Tao, Mingxin Ye, Junjie Xu, Ying Wang, Qiong Qian, Yi Hu & Yihua Wang,
2022, Respiratory Research, 23
Type: article
Yuan Yuan, Guoqiang Qiao, Jiajiao Zhou, Yilu Zhou, Yali Li, Xia Li, Zhenglin Jiang & Yihua Wang,
2022, Genes and Diseases
Type: article
Michael Eyres, Joseph A. Bell, Elizabeth R. Davies, Aurelie Fabre, Aiman Alzetani, Sanjay Jogai, Ben G. Marshall, David. A. Johnston, Zijian Xu, Sophie V. Fletcher, Yihua Wang, Gayle Marshall, Donna E. Davies, Emily Offer & Mark G. Jones,
2022, Cell Reports, 40(7)
Type: article